Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, and pharmacokinetics of single and multiple doses of YZJ-1139 in healthy participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• YZJ-1139

Snippet

Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Conditions: Insomnia | Phase 1 | Status: COMPLETED